Multicenter case series of standalone XEN implant vs. combination with phacoemulsification in Turkish patients.

Muhsin Eraslan Altan Atakana Ozcan Volkan Dericioğlu Emine Ciloglu

Published in: International ophthalmology (2021)

The XEN implant provides significant reduction in IOP and number of medications, either standalone or combination with phacoemulsification. Both procedures need intensive postoperative care, requiring needling in approximately one-third of patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
healthcare
peritoneal dialysis
palliative care
clinical trial
cross sectional
chronic pain
quality improvement